factual

Standard GBM care yields about 5 percent five-year survival

In the control arm, glioblastoma patients receiving maximal debulking surgery, radiation, and temozolomide had a five-year survival of about 5 percent, which Bill called essentially no chance of five-year survival.

factualpending

Speaker

Bill

Evidence Quote

“in our trial, the control group who received the therapy, I just described had a five year survival of about five percent”

Source

Novocure: Using Physics to Fight Cancer— Business Breakdowns
Created: 11/19/2026, 2:27:17 AM

Your notes

Loading notes...